Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3 - Concepedia

Concepedia

Publication | Closed Access

Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3

54

Citations

7

References

2015

Year

Pooja Khatri, Darren Tayama, Geoff Cohen, Richard I. Lindley, Joanna M. Wardlaw, Sharon D. Yeatts, Joseph P. Broderick, Peter Sandercock

Abstract

This post hoc analysis in a highly selected sample of IST-3 supports the rationale of A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS) trial-a randomized, phase IIIb study to evaluate IV r-tPA in mild ischemic stroke.

References

	Year	Citations

Page 1